Syncom Formulations schedules 38th AGM for September 30, 2026

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Syncom Formulations schedules 38th AGM for September 30, 2026
  • Meeting will be held via video conferencing at 2:00 pm
  • FY26 Annual Report filed with BSE and NSE on September 7, 2026
  • Filing includes financial statements and regulatory reports
powered bylight_fuzz_icon
50338063

*this image is generated using AI for illustrative purposes only.

Syncom Formulations has scheduled its 38th Annual General Meeting (AGM) for September 30, 2026. The meeting will commence at 2:00 pm and be conducted through Video Conferencing or Other Audio Visual Means, in compliance with SEBI LODR regulations.

The company submitted the notice alongside its 38th Annual Report for the financial year ended March 31, 2026. The filing includes the balance sheet, profit and loss statement, cash flow statement, and statement of changes in equity.

Regulatory Compliance

The submission adheres to Regulation 34(1) of the SEBI (LODR) Regulations, 2015. The documents were filed on September 7, 2026, with both the Bombay Stock Exchange and the National Stock Exchange of India.

The annual report also contains the Board’s Report, Corporate Governance Report, Business Responsibility and Sustainability Report (BRSR), and the Auditors’ Report along with its annexures.

Accessing Documents

Shareholders and stakeholders can access the annual report and related documents on the company’s official website. The filings are also available on the respective exchange portals.

Vaishali Agrawal, Company Secretary and Compliance Officer, signed the submission digitally.

Historical Stock Returns for Syncom Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
-1.51%+4.16%+52.41%+67.11%+18.19%0.0%

How might the financial performance detailed in the 38th Annual Report influence Syncom Formulations' dividend policy or share buyback plans?

What specific sustainability initiatives outlined in the Business Responsibility and Sustainability Report (BRSR) could impact the company's long-term operational costs or regulatory standing?

Are there any proposed changes to the Board of Directors or executive compensation structures that shareholders should scrutinize during the upcoming AGM?

Syncom Formulations files FY26 BRSR report with sustainability metrics

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Syncom Formulations filed its BRSR report for FY26 on September 7, 2026
  • Exports drive 82.94% of total standalone sales turnover of ₹48,657.28 lakh
  • Total energy consumption increased to 65,68,586.4 units in FY26
  • Permanent employee turnover rose to 28% from 25% in the prior year
  • Pharmaceutical manufacturing contributes 92.62% of entity turnover
powered bylight_fuzz_icon
50337859

*this image is generated using AI for illustrative purposes only.

Syncom Formulations has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The submission, made pursuant to Regulation 34(2)(f) of the SEBI (LODR) Regulations, 2015, outlines the company’s environmental, social, and governance disclosures.

The report confirms that pharmaceutical manufacturing accounts for 92.62% of the entity’s turnover. Exports remain a dominant revenue driver, contributing 82.94% of total standalone sales turnover of ₹48,657.28 lakh. Domestic sales accounted for the remaining 17.05%.

Workforce and Governance

As of March 31, 2026, the company employed a total of 2,429 employees and 361 workers. Permanent employees constituted the majority of the staff, with 717 individuals in that category. The gender distribution shows 94% male and 6% female representation among employees.

Turnover rates for permanent employees stood at 28% in FY26, an increase from 25% in FY25 and significantly lower than the 39% recorded in FY24. For permanent workers, the turnover rate remained stable at 9% compared to 8% in the previous year.

Environmental Disclosures

Total energy consumption rose to 65,68,586.4 units in FY26 from 53,37,685 units in FY25. Renewable energy sources contributed 11,76,680.4 units, while non-renewable sources accounted for 53,91,906 units. Water withdrawal remained largely consistent at 48,114 kilolitres, down slightly from 48,633 kilolitres in the prior year.

What the Numbers Show

The data reveals a distinct divergence in employee retention stability between fiscal years. While the overall turnover rate for permanent employees decreased from 39% in FY24 to 25% in FY25, it rebounded to 28% in FY26. This volatility contrasts with the steady 9% turnover rate for permanent workers over the same period, suggesting differing retention dynamics between salaried staff and industrial labor.

Metric FY26 FY25 FY24
Permanent Employee Turnover 28% 25% 39%
Permanent Worker Turnover 9% 8% 6%
Total Energy Consumption 65,68,586.4 53,37,685 -
Water Withdrawal (KL) 48,114 48,633 -

The company reported no fatalities or high-consequence work-related injuries in FY26. Air emissions metrics showed reductions in NOx (58.94 mg/m³ vs 65.42 mg/m³) and SOx (39.86 mg/m³ vs 44.2 mg/m³) compared to the previous year.

Historical Stock Returns for Syncom Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
-1.51%+4.16%+52.41%+67.11%+18.19%0.0%

How might the rebound in permanent employee turnover to 28% impact Syncom Formulations' operational efficiency and future recruitment costs?

What specific strategies is Syncom planning to implement to increase female representation from the current 6% in its workforce?

Given that 83% of revenue comes from exports, how exposed is Syncom to potential currency fluctuations or shifting global pharmaceutical demand trends?

More News on Syncom Formulations

1 Year Returns:+18.19%